Prolastin-c

Ended Awarded Last action

Contract number
36C26024F0023
Awardee
Awarding agency
Obligated
$288,931

Award facts

Contract value 100% obligated
$288,931.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Los Angeles, CA 90032, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$208,069
Original award $497,000

About this award

This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024.

Grifols USA LLC holds a Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, valued at over $1.3 billion, which allows various civilian agencies to procure pharmaceutical products. Under this schedule, Grifols also has a $107.5 million Blanket Purchase Agreement specifically for PROLASTIN-C. Additionally, Grifols has provided PROLASTIN-C and other vaccines and pharmaceutical products to other federal agencies, including the Department of Justice's Bureau of Prisons and the Centers for Disease Control and Prevention (CDC), through various indefinite delivery vehicles (IDVs).

Quick answers

Who was awarded contract 36C26024F0023?

36C26024F0023 was awarded to Grifols USA LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2023.

How much is contract 36C26024F0023 worth?

The government has obligated $288,931 on 36C26024F0023.

Is contract 36C26024F0023 an order under another contract?

Yes. 36C26024F0023 is a delivery order under 36F79722D0090, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0023 competed?

The extent of competition for 36C26024F0023 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award